5M3Y
Crystal structure of human glycosylated angiotensinogen
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04-1 |
Synchrotron site | Diamond |
Beamline | I04-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2013-07-06 |
Detector | DECTRIS PILATUS 2M |
Wavelength(s) | 0.987 |
Spacegroup name | P 41 |
Unit cell lengths | 71.350, 71.350, 125.310 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 46.800 - 2.300 |
R-factor | 0.1726 |
Rwork | 0.170 |
R-free | 0.18890 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2wxw |
RMSD bond length | 0.002 |
RMSD bond angle | 0.483 |
Data reduction software | iMOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.800 | 2.380 |
High resolution limit [Å] | 2.300 | 2.300 |
Rmerge | 0.057 | 0.702 |
Number of reflections | 27827 | |
<I/σ(I)> | 16.6 | |
Completeness [%] | 99.9 | |
Redundancy | 6.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293.15 | 2.0M Ammonium Sulfate, 0.1M Bicine, pH9.0 |